Kaken Pharmaceutical
10 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of KP-001 (NCT06619054) | Kaken Pharmaceutical | 2024-10-24 |
| A Study to Evaluate the Effects of KP-001 on the QT/QTc Intervals in Healthy Adults (NCT06649942) | Kaken Pharmaceutical | 2024-10-01 |
| A Study to Determine the Effect of KP-001 on Metformin and Midazolam Pharmacokinetics and the Effect of Clarithromycin on KP-001 Pharmacokinetics in Healthy Adult Participants (NCT06227832) | Kaken Pharmaceutical | 2023-12-15 |
Track Kaken Pharmaceutical automatically
Every clearance here is in the API, with alerts when new ones post.